FCPM III SERVICES B.V.
Top Portfolio Positions
9 positions ·
$714,925,124 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
9,198,900 | $294,456,788 | 41.19% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
4,644,386 | $84,202,718 | 11.78% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
4,117,354 | $73,453,595 | 10.27% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
9,632,561 | $65,597,740 | 9.18% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
3,226,400 | $65,592,712 | 9.17% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
2,441,000 | $63,221,900 | 8.84% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
1,677,852 | $30,822,141 | 4.31% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
2,808,368 | $21,484,015 | 3.01% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
3,468,430 | $16,093,515 | 2.25% |
Portfolio Trend
10 quarters · across all stocks
Holdings in ENGN
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65,597,740 | 9,632,561 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $86,982,024 | 9,632,561 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $65,790,391 | 9,632,561 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $35,062,521 | 9,632,561 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,153,872 | 9,632,561 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $64,056,530 | 9,632,561 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $57,274,476 | 8,677,951 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $81,833,077 | 8,677,951 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $147,091,269 | 8,677,951 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $80,097,486 | 8,677,951 | Shares | Defined | 2024-03-07 | |
| No 13F history on record for this holder in this stock. | ||||||